Preclinical study of iv administration of the methanol extraction residue of bacillus Calmette-Guérin
Vogl, S.E.; Lumb, G.; Bekesi, J.G.; Holland, J.F.
Cancer Treatment Reports 61(5): 901-903
1977
ISSN/ISBN: 0361-5960 PMID: 329984 Document Number: 122535
Document emailed within 1 workday
Related Documents
Bjornsson, S.; Takita, H.; Kuberka, N.; Preisler, H.; Catane, H.; Higby, D.; Henderson, E. 1978: Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage IIi lung cancer Cancer Treatment Reports 62(4): 505-510Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Goupille, P.; Valat, J.P. 1996: Arthritis after bacillus Calmette-Guérin therapy Journal of Rheumatology 23(8): 1481-1482
Brosman, S.A. 1992: Bacillus Calmette-Guérin immunotherapy. Techniques and results Urologic Clinics of North America 19(3): 557-564
Merrin, C.; Han, T.; Klein, E.; Wajsman, Z.; Murphy, G.P. 1975: Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin Cancer ChemoTherapy Reports 59(1): 157-163
Vázquez-Lavista, L.G.; Flores-Balcázar, C.H.é; Llorente, L. 2007: The bacillus Calmette-Guérin as immunomodulator in bladder cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 146-152
Mitsogiannis, I.C.; Psaroudaki, Z.; Perrea, D.; Paniara, O.; Melekos, M.D.; Zervas, A.; Mitropoulos, D. 2006: In vitro biocompatibility between mitomycin-C (MMC) and bacillus Calmette-Guerin (BCG) Anticancer Research 26(6b): 4569-4573
Cerdá de Palou, E.; de Santy, H.P.R.M. 2003: Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG) Nederlands Tijdschrift Voor Geneeskunde 147(12): 569-572
Nesher, G. 1999: Bacillus Calmette-Guérin induced reactive arthritis Journal of Rheumatology 26(7): 1638
Filardi, M.J.; Codish, S.D.; Civerchia, L.; Howard, R.K.; McKneally, M.F. 1979: Toxicity of intrapleural Bacillus Calmette-Guérin treatment in animals Cancer Research 39(9): 3673-3676
De Saint Martin, L.; Boiron, C.; Poveda, J.D.; Herreman, G. 1993: Generalized BCG infection after intravesical instillations of Calmette-Guerin bacillus Presse Medicale 22(29): 1352-1356
Borré, S.; Brustia, D.; Rosa, F.; Brondolo, R.; Rizzo, G.; Garavelli, P.L. 2002: Calmette-Guerin bacillus disseminated infection after intravesical instillation Recenti Progressi in Medicina 93(4): 247-248
Debruyne, F.M.; Witjes, J.A.; vd Meijden, A.P. 1990: Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview Archivos Espanoles de Urologia 43(Suppl): 133-138
Skaugen, P. 1997: Bacillus Calmette-Guerin therapy for bladder carcinoma in situ: use in a clinical setting Urologic Nursing 17(2): 69-71
Zodpey, S.P.; Maldhure, B.R.; Kulkarni, S.W. 2004: Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis Journal of Communicable Diseases 36(3): 159-165
Valdespino Gómez, J.L. 1997: Update topic: the uses and effects of the Calmette-Guérin Mycobacterium bovis bacillus (BCG vaccine) Salud Publica de Mexico 39(2): 93-94
Milas, L.; Maillefert, J.F.; Michel, F.; Piroth, C.; Wautot, A.; Tavernier, C. 1999: Refractory arthropathy after intravesical bacillus Calmette-Guérin therapy. Usefulness of isoniazide Revue du Rhumatisme 66(2): 106-108
Lamm, D.L.; Harris, S.C.; Gittes, R.F. 1977: Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors Investigative Urology 14(5): 369-372
Sparks, F.C.; Breeding, J.H. 1974: Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase Cancer Research 34(12): 3262-3269